Asian Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.00 Cr
as on 24-10-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 162.85 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.25 Cr
as on 24-10-2024
- Revenue -10.30%
(FY 2023)
- Profit -17.12%
(FY 2023)
- Ebitda -7.99%
(FY 2023)
- Net Worth 21.01%
(FY 2023)
- Total Assets 8.30%
(FY 2023)
About Asian Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹162.85 Cr. The company has closed loans amounting to ₹2.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Milind Shirodkar and Sampada Shirodkar serve as directors at the Company.
- CIN/LLPIN
U85110MH2004PTC146813
- Company No.
146813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Asian Institute Of Medical Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Shirodkar  | Director | 08-Jun-2004 | Current |
| Sampada Shirodkar | Director | 08-Jun-2004 | Current |
Financial Performance of Asian Institute Of Medical Sciences.
Asian Institute Of Medical Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.3% decrease. The company also saw a substantial fall in profitability, with a 17.12% decrease in profit. The company's net worth Soared by an impressive increase of 21.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Institute Of Medical Sciences?
In 2023, Asian Institute Of Medical Sciences had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 11 May 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 31 Mar 2023 | ₹21.00 Cr | Open |
Yes Bank Limited Creation Date: 12 Sep 2022 | ₹2.45 Cr | Open |
How Many Employees Work at Asian Institute Of Medical Sciences?
Unlock and access historical data on people associated with Asian Institute Of Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asian Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asian Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
